BiotechTube

Anidulafungin + Voriconazole

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Candidemia

Conditions

Candidemia, Invasive Candidiasis

Trial Timeline

Feb 1, 2008 → Oct 1, 2009

NCT ID
NCT00548262

About Anidulafungin + Voriconazole

Anidulafungin + Voriconazole is a approved stage product being developed by Pfizer for Candidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT00548262. Target conditions include Candidemia, Invasive Candidiasis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00548262ApprovedCompleted

Competing Products

9 competing products in Candidemia

See all competitors
ProductCompanyStageHype Score
micafungin + Micafungin + CaspofunginAstellas PharmaApproved
85
MicafunginAstellas PharmaApproved
85
AmBisomeGilead SciencesApproved
84
Anidulafungin/FluconazolePfizerPhase 3
76
Anidulafungin + FluconazolePfizerPhase 3
76
AnidulafunginPfizerPhase 3
76
Fosmanogepix + Fosmanogepix + Caspofungin + Fluconazole + Placebo + Placebo + Placebo + PlaceboBasilea PharmaceuticaPhase 3
72
APX001Basilea PharmaceuticaPhase 2
47
APX001Basilea PharmaceuticaPhase 2
47

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84